Table 4.
Univariate logistic regression analysis of the prevalence of AF versus clinical features
| OR | p Value | |
|---|---|---|
| Age | 1.00 (0.96–1.04) | 0.68 |
| Female | 2.00 (0.80–5.20) | 0.14 |
| NYHA class ≥II | 0.68 (0.26–1.76) | 0.48 |
| MWT | 3.04 (0.07–307.2) | 0.58 |
| LAD ≥50 mm | 8.87 (2.77–31.9) | 0.0002 |
| LVEF | 5.97 (0.47–78.1) | 0.16 |
| E/e’ lateral ≥15 | 1.73 (0.61–4.89) | 0.42 |
| Max PG | 8.47 (1.31–75.5) | 0.23 |
| High BNP | 2.46 (0.97–6.21) | 0.06 |
| High cTnT | 3.34 (1.33–8.42) | 0.01 |
AF, atrial fibrillation; High BNP, high B-type natriuretic peptide level (serum BNP level ≥200 pg/mL); High cTnT, high cardiac troponin T level (serum cTnT level ≥0.014 ng/mL); LAD, left atrium diameter; LV, left ventricular; LVEF, LV ejection fraction; Max PG, maximum peak gradient in the LV; MWT, maximum LV wall thickness; NYHA class, New York Heart Association functional class.